Inhibition of insulin-like growth factor receptor: end of a targeted therapy?
about
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung CancerCompounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cellsGlycemic Index, Glycemic Load, and Lung Cancer Risk in Non-Hispanic Whites.IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.
P2860
Q26740210-9EF90282-7B1B-4C83-A79C-A7888BFB5633Q28468664-606EF076-6D15-465D-AD68-FB4CBF28FC9BQ35946401-52A754CA-DABA-4BB8-845A-FEEFE2701020Q36413323-CEFC050A-17B6-4C79-A8BC-1A2E3C5FC325Q37179512-F45EF5D5-7445-4266-923F-7B399A489CEFQ45122871-5ED709D7-3A35-4B57-86F1-E7260BB4CC63Q47994454-8197342C-2496-4F4F-A532-5020A14B2969
P2860
Inhibition of insulin-like growth factor receptor: end of a targeted therapy?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of insulin-like growth factor receptor: end of a targeted therapy?
@en
type
label
Inhibition of insulin-like growth factor receptor: end of a targeted therapy?
@en
prefLabel
Inhibition of insulin-like growth factor receptor: end of a targeted therapy?
@en
P2860
P1476
Inhibition of insulin-like growth factor receptor: end of a targeted therapy?
@en
P2093
Rathi N Pillai
Suresh S Ramalingam
P2860
P356
10.3978/J.ISSN.2218-6751.2012.11.05
P577
2013-02-01T00:00:00Z